<DOC>
	<DOCNO>NCT01447381</DOCNO>
	<brief_summary>While many patient atopic dermatitis ( eczema ) manage topical cream treatment itch , child severe , long-standing disease need treatment oral medication decrease ability immune system react . However , enough information proper use medication well work compare . The current study look response child treat medication provide information improve use .</brief_summary>
	<brief_title>Systemic Therapies Pediatric Atopic Dermatitis</brief_title>
	<detailed_description>Severe and/or refractory case atopic dermatitis ( AD ) require systemic immunosuppressive therapy disease control , yet study regard appropriate use drug pediatric AD even less data comparing . The current observational study observe effect therapy child moderate severe atopic dermatitis treat . These drug observe cyclosporine , azathioprine , mycophenolate mofetil , methotrexate .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Diagnosis moderate , severe , severe atopic dermatitis meeting Hanifin Rajka criterion Needs systemic therapy ( e.g . cyclosporine , azathioprine , mycophenolate mofetil , methotrexate ) severe atopic dermatitis Subject severe recalcitrant disease interrupt daily life evidence fulfil 2 follow 4 criterion : Failure multimodal therapy include emollients/barrier repair , topical antiinflammatory agent ( medium high potency topical corticosteroid , and/or lowpotency topical calcineurin inhibitor facial/intertriginous area ) , antihistamines Significant impairment quality life ( physical , psychological , emotional ) significant sleep disruption , poor school performance , frequent school absenteeism , per judgement investigator . Inability receive , prior failure , need one course phototherapy Prior failure need one course another oral immunosuppressive medication No serious medical condition precludes use oral immunosuppressive base subject 's medical history , physical examination , safety laboratory test . Negative PPD within last year prior study initiation . Female childbearing potential negative pregnancy test time start systemic drug consent abstinent use effective method contraception study . Effective contraception define IUD , condom spermicide , diaphragm spermicide , stable use hormonal contraceptive ( oral , implant , injection transdermal patch ) begin least 1 month prior start systemic drug . Subject parent/guardian willing able comply study instruction return clinic require visit . Female pregnant , nursing , plan pregnancy study period . Concurrent participation another clinical trial investigational drug device may impact individual 's atopic dermatitis . Subjects clinically significant hepatic disease , history lymphoma myelosuppression , low TMPT activity ( start azathioprine ) , renal disease ( start cyclosporine azathioprine ) , hypertension ( start cyclosporine ) , blood dyscrasia , central nervous system disorder , uncontrolled seizure peripheral neuropathy , take systemic medication could interact adversely study medicine ( e.g . erythromycin use cyclosporine ) . Subjects underlying disease Investigator deem uncontrolled , pose concern subject safety participate study . Subject history clinically significant drug alcohol abuse last year . Subject consider Investigator , reason , unsuitable candidate study . Active systemic infection could worsen systemic therapy AD .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>